208 related articles for article (PubMed ID: 33565511)
1. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
Cui Y; Wang W; Yao S; Qiu Z; Cong L
J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
[TBL] [Abstract][Full Text] [Related]
2. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
3. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
Wang WB; Cui YG; Yao SY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
[TBL] [Abstract][Full Text] [Related]
4. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
Yan L; Yao Y; Wang LH; Wang ML; Fu XH
Genet Mol Res; 2015 Nov; 14(4):15090-5. PubMed ID: 26634471
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
Cheng M; Chen Y; Yu X; Tian Z; Wei H
BMC Cancer; 2008 May; 8():156. PubMed ID: 18513434
[TBL] [Abstract][Full Text] [Related]
6. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
[TBL] [Abstract][Full Text] [Related]
7. [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
Zhou Q; Shi Y; Chen J; Liu B; Wang Y; Zhu D; Zhang HT; Xu P; Gong Y; Chen G; Wei S; Qiu X; Niu Z; Chen X; Lei Z; Duan L; Wu Z
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):86-106. PubMed ID: 21342639
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between the mRNA levels of BCRP and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
Chen D; Han W; Wang P; Ma H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):202-207. PubMed ID: 36709941
[TBL] [Abstract][Full Text] [Related]
9. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.
Iwao K; Watanabe T; Fujiwara Y; Takami K; Kodama K; Higashiyama M; Yokouchi H; Ozaki K; Monden M; Tanigami A
Int J Cancer; 2001 Feb; 91(4):433-7. PubMed ID: 11251963
[TBL] [Abstract][Full Text] [Related]
11. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
Tang Y; Xu L
J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
14. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
Tan S; Cheng Z; Ma Y; Tan S; Yin Z; Hu W; Yu F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1236-41. PubMed ID: 21200090
[TBL] [Abstract][Full Text] [Related]
15. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy].
Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis.
Zhang X; Xie J; Yu C; Yan L; Yang Z
Exp Ther Med; 2014 Feb; 7(2):360-364. PubMed ID: 24396405
[TBL] [Abstract][Full Text] [Related]
17. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected].
Mitas M; Hoover L; Silvestri G; Reed C; Green M; Turrisi AT; Sherman C; Mikhitarian K; Cole DJ; Block MI; Gillanders WE
J Mol Diagn; 2003 Nov; 5(4):237-42. PubMed ID: 14573783
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
19. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
Zhang P; Liu Y; Chen J; Song S; Shang Z
Zhongguo Fei Ai Za Zhi; 2006 Dec; 9(6):506-10. PubMed ID: 21182811
[TBL] [Abstract][Full Text] [Related]
20. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]